|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||515.95 g/mol g·mol−1|
|3D model (JSmol)|
Taranabant (codenamed MK-0364) is a cannabinoid receptor type 1 inverse agonist that was investigated as a potential treatment for obesity due to its anorectic effects. It was discovered by Merck & Co.
|This cannabinoid related article is a stub. You can help Wikipedia by expanding it.|